True Wealth Design, LLC Biotechnology

True Wealth Design, LLC

$284 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IPSC Century Therapeutics, Inc.	$30.6M	$149,000 0.0% of portfolio	266	Q2 2025 Added 383.64%
BMEA Biomea Fusion, Inc.	$48.3M	$146,000 0.0% of portfolio	81	Q2 2025 Added 1.25%
YMAB Y M Abs Therapeutics, Inc.	$372M	$131,000 0.0% of portfolio	29	Q2 2025 Added 70.59%
FULC Fulcrum Therapeutics, Inc.	$340M	$111,000 0.0% of portfolio	16	Q2 2025 Added 60.0%
NAUT Nautilus Biotechnology, Inc.	$88.5M	$107,000 0.0% of portfolio	147	Q2 2025 Added 1,125.0%
KROS Keros Therapeutics, Inc.	$353M	$81,000 0.0% of portfolio	6	Q2 2025 Added 100.0%
XOMA Xoma Corp	$326M	$76,000 0.0% of portfolio	3	Q1 2025 New
ATOS Atossa Therapeutics, Inc.	$97.5M	$71,000 0.0% of portfolio	85	Q2 2025 Added 23.19%
TSHA Taysha Gene Therapies, Inc.	$141M	$70,000 0.0% of portfolio	30	Q2 2025 Reduced 77.27%
SCPH Sc Pharmaceuticals Inc.	$132M	$61,000 0.0% of portfolio	16	Q2 2025 Reduced 50.0%
TCRX T Scan Therapeutics, Inc.	$31.6M	$61,000 0.0% of portfolio	42	Q2 2025 Added 27.27%
ADCT Adc Therapeutics Sa	$228M	$57,000 0.0% of portfolio	21	Q2 2025 Reduced 77.42%
IBRX Immunity Bio, Inc.	$989M	$53,000 0.0% of portfolio	20	Q2 2025 Added 150.0%
FHTX Foghorn Therapeutics Inc.	$203M	$52,000 0.0% of portfolio	11	Q2 2025 Reduced 86.42%
KOD Kodiak Sciences Inc.	$443M	$49,000 0.0% of portfolio	13	Q1 2025 New
GALT Galectin Therapeutics Inc	$224M	$47,000 0.0% of portfolio	22	Q2 2025 Added 4.76%
STOK Stoke Therapeutics, Inc.	$533M	$46,000 0.0% of portfolio	4	Q2 2025 New
CCCC C4 Therapeutics, Inc.	$110M	$45,000 0.0% of portfolio	31	Q2 2025 Added 244.44%
ABOS Acumen Pharmaceuticals, Inc.	$51M	$41,000 0.0% of portfolio	35	Q2 2025 Added 20.69%
OLMA Olema Pharmaceuticals, Inc.	$215M	$39,000 0.0% of portfolio	9	Q2 2025 Reduced 78.05%
STTK Shattuck Labs, Inc.	$32.2M	$37,000 0.0% of portfolio	46	Q2 2025 Added 187.5%
SVRA Savara Inc	$294M	$35,000 0.0% of portfolio	15	Q2 2025 Reduced 63.41%
ATNM Actinium Pharmaceuticals, Inc.	$38M	$34,000 0.0% of portfolio	24	Q2 2025 Added 41.18%
CABA Cabaletta Bio, Inc.	$38.6M	$26,000 0.0% of portfolio	17	Q2 2025 Reduced 73.02%
ELYM Eliem Therapeutics, Inc.	$109M	$24,000 0.0% of portfolio	19	Q2 2025 Added 58.33%
VERU Veru Inc.	$254M	$24,000 0.0% of portfolio	40	Q2 2025 Added 29.03%
ARVN Arvinas, Inc.	$361M	$23,000 0.0% of portfolio	3	Q2 2025 Reduced 86.96%
PLRX Pliant Therapeutics, Inc.	$81.8M	$23,000 0.0% of portfolio	19	Q2 2025 New
ADGI Adagio Therapeutics, Inc.	$505M	$21,000 0.0% of portfolio	28	Q2 2025 Reduced 46.15%
XBIT X Biotech Inc.	$90.4M	$21,000 0.0% of portfolio	7	Q2 2025 Added 40.0%
APLT Applied Therapeutics Inc.	$21.1M	$19,000 0.0% of portfolio	59	Q2 2025 New
IGMS Igm Biosciences, Inc.	$37.7M	$16,000 0.0% of portfolio	14	Q2 2025 Reduced 94.83%
MGNX Macrogenics Inc	$90.3M	$15,000 0.0% of portfolio	12	Q2 2025 Reduced 29.41%
HOWL Werewolf Therapeutics, Inc.	$35.4M	$15,000 0.0% of portfolio	13	Q2 2025 Reduced 40.91%
PRLD Prelude Therapeutics Inc	$30.6M	$11,000 0.0% of portfolio	13	Q2 2025 Added 30.0%
ZNTL Zentalis Pharmaceuticals, Inc.	$80.3M	$11,000 0.0% of portfolio	9	Q2 2025 Reduced 88.75%
ALXO Alx Oncology Holdings Inc	$25.3M	$7,000 0.0% of portfolio	15	Q2 2025 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$159M	$7,000 0.0% of portfolio	11	Q2 2025 Reduced 93.53%
GERN Geron Corp	$510M	$6,000 0.0% of portfolio	4	Q2 2025 Reduced 75.0%
OVID Ovid Therapeutics Inc.	$38.7M	$3,000 0.0% of portfolio	8	Q2 2025 Reduced 75.0%
ELEV Elevation Oncology, Inc.	$8.39M	$2,000 0.0% of portfolio	3	Q2 2025 Reduced 90.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.